Concepedia

S. Lockton

SL

Statistics

Publications

9

Citations

932

H-Index

9

Active since

1995

Affiliations

Prometheus Biosciences (United States)(Current)

University of Toronto

Western University

Mount Sinai Hospital

Prometheus (United States)

S. Lockton is an author at Prometheus Biosciences (United States) specializing in inflammation, life sciences, and inflammatory biomarkers.

Publications per year

1995–2015

9

Publications

9

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Niels Vande Casteele, Reena Khanna, Barrett G. Levesque et al. · Gut · 2014 · 286 citations · Full text

, , +17

The Relationship between Stool Hardness and Stool Composition in Breast- and Formula-Fed Infants

Paul T. Quinlan, S. Lockton, James Irwin et al. · Journal of Pediatric Gastroenterology and Nutrition · 1995 · 219 citations

, , +17

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Filip Baert, David Drobne, Ann Gils et al. · Clinical Gastroenterology and Hepatology · 2014 · 134 citations · Full text

, , +14

Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients

Scott E. Plevy, Mark S. Silverberg, S. Lockton et al. · Inflammatory Bowel Diseases · 2013 · 126 citations · Full text

, , +17

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

Barrett G. Levesque, Gordon R. Greenberg, Guangyong Zou et al. · Alimentary Pharmacology & Therapeutics · 2014 · 100 citations · Full text

, , +17

1–5 of 9